Global X S&P Biotech ETF is a sector & thematic ETF from Global X — 157 holdings, with $39.6m under management. 88% of its money is in health care. Its two largest holdings, MODERNA INC and TWIST BIOSCIENCE, make up 4% of the fund. It charges 0.45% a year.
- TypeSector & thematic
- IssuerGlobal X
- Size$39.6m
- Cost0.45% a year
- Holdings157
- Top sectorHealth Care 88%
- Top 2 holdings4%
the last 3 months
$10,000 in CURE fell to $9,441.
No payout is counted in this period.
−5.59% by price
▲ ①What added the most
One company added the most: Moderna
Moderna added +$114 on every $10,000. Its share price rose 34% over the period, in its own currency. On average $253 of every $10,000 in CURE was in Moderna.
What moved it
▼ ②6 Nov · What took the most
One sector took the most: Health Care
Health Care took $888 on every $10,000. On average $8,835 of every $10,000 in CURE was in it. The biggest part: Arrowhead, −$69.
Where they are
The companies by country
On $10,000 at the start
- Start
- $10,000
- End
- $9,441
- High
- $10,284
- Low
- $9,100
High and low were 12% apart.
How it adds up, on $10,000
What you own
Of every $10,000 in CURE
- Moderna$253
- Twist$181
- Natera$161
- The other 140$9,405
The news · estimated
What the news did
Results above what was expected added +$201; results below what was expected took $147 on $10,000.
Other news
Compare
Funds like CURE
- PAVEGlobal X US Infrastructure Development ETF97% of its country mix matchesCompare with CURE
- FANGGlobal X FANG+ ETF97% of its country mix matchesCompare with CURE
- FHNGGlobal X FANG+ (Currency Hedged) ETF97% of its country mix matchesCompare with CURE
- ITEKiShares Future Tech Innovators ETF97% of its country mix matchesCompare with CURE
- Compare CURE with any fund →